Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Syncytial Virus, Human | 4 | 2025 | 233 | 1.640 |
Why?
|
| Enterovirus | 2 | 2024 | 52 | 1.370 |
Why?
|
| Enterovirus Infections | 2 | 2024 | 49 | 1.350 |
Why?
|
| Viruses | 3 | 2024 | 128 | 1.040 |
Why?
|
| Picornaviridae Infections | 1 | 2024 | 53 | 0.840 |
Why?
|
| Respiratory Syncytial Virus Infections | 3 | 2025 | 377 | 0.790 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 240 | 0.560 |
Why?
|
| Bodily Secretions | 1 | 2016 | 7 | 0.510 |
Why?
|
| Virus Diseases | 1 | 2019 | 291 | 0.500 |
Why?
|
| Respiratory Tract Infections | 1 | 2019 | 295 | 0.490 |
Why?
|
| Influenza, Human | 2 | 2022 | 700 | 0.490 |
Why?
|
| Nasopharynx | 1 | 2016 | 87 | 0.490 |
Why?
|
| Bacterial Infections | 1 | 2019 | 329 | 0.490 |
Why?
|
| Cytokines | 2 | 2024 | 1397 | 0.470 |
Why?
|
| Bronchiolitis | 1 | 2016 | 123 | 0.460 |
Why?
|
| Antiviral Agents | 1 | 2018 | 825 | 0.390 |
Why?
|
| Viral Load | 3 | 2025 | 411 | 0.390 |
Why?
|
| Organoids | 2 | 2025 | 299 | 0.370 |
Why?
|
| Infant | 9 | 2025 | 13263 | 0.340 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2023 | 492 | 0.280 |
Why?
|
| Infant, Newborn | 6 | 2023 | 8640 | 0.270 |
Why?
|
| Viral Tropism | 1 | 2025 | 53 | 0.230 |
Why?
|
| Nose | 1 | 2025 | 105 | 0.230 |
Why?
|
| RNA, Viral | 3 | 2021 | 563 | 0.230 |
Why?
|
| Virus Shedding | 2 | 2021 | 82 | 0.220 |
Why?
|
| Nasal Mucosa | 1 | 2024 | 68 | 0.220 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 356 | 0.190 |
Why?
|
| Antigens, Viral | 1 | 2024 | 440 | 0.190 |
Why?
|
| Fever | 1 | 2024 | 312 | 0.180 |
Why?
|
| Humans | 17 | 2025 | 134223 | 0.170 |
Why?
|
| Immunoglobulin A | 1 | 2021 | 217 | 0.170 |
Why?
|
| Respiratory System | 1 | 2020 | 98 | 0.160 |
Why?
|
| Infant, Low Birth Weight | 1 | 2020 | 176 | 0.160 |
Why?
|
| Immunoglobulin G | 1 | 2021 | 810 | 0.150 |
Why?
|
| Hand, Foot and Mouth Disease | 1 | 2017 | 3 | 0.140 |
Why?
|
| Vietnam | 1 | 2017 | 65 | 0.140 |
Why?
|
| Coinfection | 1 | 2019 | 183 | 0.130 |
Why?
|
| Pandemics | 2 | 2022 | 1193 | 0.130 |
Why?
|
| Angiostrongylus cantonensis | 1 | 2016 | 9 | 0.130 |
Why?
|
| Strongylida Infections | 1 | 2016 | 15 | 0.130 |
Why?
|
| Prospective Studies | 2 | 2019 | 6617 | 0.130 |
Why?
|
| Nasal Lavage Fluid | 1 | 2016 | 14 | 0.130 |
Why?
|
| Fever of Unknown Origin | 1 | 2016 | 45 | 0.130 |
Why?
|
| Female | 11 | 2025 | 72055 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 1835 | 0.120 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 1205 | 0.120 |
Why?
|
| Bacteria | 1 | 2019 | 537 | 0.110 |
Why?
|
| Infant, Premature | 1 | 2020 | 857 | 0.110 |
Why?
|
| Cohort Studies | 1 | 2024 | 5225 | 0.110 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 1161 | 0.100 |
Why?
|
| Child | 4 | 2025 | 25918 | 0.100 |
Why?
|
| Vaccines | 1 | 2017 | 380 | 0.100 |
Why?
|
| Hospitalization | 2 | 2023 | 1919 | 0.090 |
Why?
|
| Immunity, Innate | 2 | 2025 | 415 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 3759 | 0.090 |
Why?
|
| Phenotype | 1 | 2021 | 4611 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2019 | 3754 | 0.080 |
Why?
|
| Male | 6 | 2025 | 66216 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2025 | 14898 | 0.070 |
Why?
|
| Adolescent | 3 | 2023 | 20648 | 0.070 |
Why?
|
| Adult | 5 | 2025 | 31963 | 0.060 |
Why?
|
| Pregnancy | 3 | 2023 | 7600 | 0.060 |
Why?
|
| Disease Susceptibility | 1 | 2024 | 320 | 0.050 |
Why?
|
| Peripartum Period | 1 | 2023 | 29 | 0.050 |
Why?
|
| Host-Pathogen Interactions | 1 | 2025 | 265 | 0.050 |
Why?
|
| Virus Replication | 1 | 2024 | 636 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2021 | 220 | 0.040 |
Why?
|
| Seasons | 1 | 2022 | 333 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2021 | 472 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2021 | 184 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1512 | 0.040 |
Why?
|
| Texas | 2 | 2021 | 3719 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2024 | 936 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2021 | 780 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 547 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 825 | 0.040 |
Why?
|
| Age Factors | 1 | 2025 | 2997 | 0.040 |
Why?
|
| Transcriptome | 1 | 2025 | 1134 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 1922 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2025 | 2563 | 0.040 |
Why?
|
| Lung | 1 | 2025 | 1578 | 0.030 |
Why?
|
| Proteus mirabilis | 1 | 2016 | 12 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 2016 | 100 | 0.030 |
Why?
|
| Meningitis | 1 | 2016 | 101 | 0.030 |
Why?
|
| Prednisone | 1 | 2016 | 258 | 0.030 |
Why?
|
| Eosinophilia | 1 | 2016 | 106 | 0.030 |
Why?
|
| Incidence | 1 | 2023 | 3424 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2021 | 1630 | 0.030 |
Why?
|
| Middle Aged | 2 | 2025 | 29431 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 7244 | 0.020 |
Why?
|
| Risk Factors | 1 | 2023 | 11196 | 0.020 |
Why?
|
| United States | 1 | 2022 | 11798 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 9964 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3869 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 17591 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 21822 | 0.010 |
Why?
|
| Animals | 1 | 2016 | 36524 | 0.010 |
Why?
|